Niva Bupa Health Insurance Company Limited has announced key leadership changes following a board meeting held on May 8, 2026, in line with its regulatory disclosure to stock exchanges under SEBI’s Listing Obligations and Disclosure Requirements (LODR) Regulations.
The company has elevated Ankur Kharbanda to the position of Executive Director and Deputy Chief Executive Officer, effective immediately. Kharbanda, who currently serves as Executive Director and Chief Business Officer, has been with Niva Bupa since April 2020 and leads the company’s sales and distribution functions. With over two decades of experience in the health insurance sector, he is an alumnus of FORE School of Management, Delhi.
In addition to the leadership elevation, the board has approved the appointment of Christopher Patrick Carroll and Siobhan Djihan Moynihan as Additional Directors in the capacity of Non-Executive Directors. Both appointments will take effect from May 15, 2026, subject to shareholder approval within three months.
The company confirmed that both Carroll and Moynihan are not debarred from holding directorial positions by any regulatory authority, including the Securities and Exchange Board of India (SEBI).
These developments come as part of Niva Bupa’s ongoing efforts to strengthen its leadership team and governance framework, aligning with its growth strategy in India’s competitive health insurance market.
